519 Preclinical evaluation of the second generation vascular disrupting agent OXI 4503
W. Shi, H.W. Salmon, A.M. Rojiani, D.W. SiemannVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80527-5
File:
PDF, 286 KB
english, 2004